ALDX Aldeyra Therapeutics, Inc.
Price Chart
Executive Summary
Two corporate insiders at Aldeyra Therapeutics purchased shares in the open market within a 7-day window, totaling $105,100. The purchases were made at prevailing market prices by a director and the principal financial officer, signaling modest confidence in the company's prospects.
Key Financial Metrics
Actionable Insight
While the dollar amount is relatively small, the fact that both a director and CFO are buying shares at current levels may indicate confidence ahead of potential catalysts. Traders should monitor for upcoming clinical updates or financing activity.
Key Facts
- Director Douglas Richard purchased 70,000 shares for $98,000 on March 19, 2026.
- Principal Financial Officer Michael Alfieri purchased 5,000 shares for $7,100 on March 18, 2026.
- Total open-market purchases amounted to $105,100 across two insiders.
- Total value represents approximately 0.095% of the company's $110M market cap.
Financial Impact
$105,100 in open-market buying by two insiders
Risk Factors
- The total value of purchases is modest (~0.1% of market cap) and may not reflect broad insider conviction.
- No additional public filings or news accompany these trades, limiting context.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (2 trades, 7d window) | cluster-ALDX-1774037884870 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Apr 27, 2026
6w ago
|
DEFA14A
| $1.57 $1.78 | ▲ +13.38% | ▲ +7.91% | $1.72 (+9.55%) |
|
Apr 20, 2026
7w ago
|
8-K
| $1.68 $1.60 | ▼ −4.76% | ▼ −9.68% | $1.72 (+2.38%) |
|
Mar 18, 2026
12w ago
|
Insider Cluster
| $1.42 $1.80 | ▲ +26.76% | ▲ +20.71% | $1.72 (+21.13%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access